Botox Breakthrough for Depression

Dive into today's episode of Aesthetic Medicine Minute, where we explore groundbreaking research on using botulinum toxin A (BTA) to treat major depressive disorder (MDD). Discover how BTA injections in the glabellar region could revolutionize depression treatment, significantly improving symptoms and potentially offering a new therapeutic option. Learn about the promising results from recent trials and the facial feedback hypothesis, which may explain the mood-lifting effects of BTA. Join us...